Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

50,425 public trials 10,704 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 20 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

NCT07567846

Conditions
Advanced Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • St Vincent's Hospital Sydney Darlinghurst, New South Wales, Australia
  • Austin Hospital Heidelberg, Victoria, Australia
View Trial Details
Recruiting

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

NCT07501702

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Neurology Offices Boca Raton, Florida, United States
  • SFM Clinical Reseach, LLC Boca Raton, Florida, United States
  • Homestead Associates in Research Homestead, Florida, United States
  • UF Health Jacksonville Respiratory Therapy (PFT and DLCO) Jacksonville, Florida, United States
View all 27 locations
View Trial Details
Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

NCT07198074

Conditions
Advanced Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
View all 267 locations
View Trial Details

Related conditions